EUROMACS-RHF Score
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–2
- Intermediate Risk2.5–4
- High Risk4.5–9.5
The EUROMACS-RHF Score calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include ra pcwp ratio elevated. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Determines risk of right ventricular heart failure in patients after left ventricular assist device (LVAD) implantation.
Clinical Indication
The EUROMACS-RHF Score is indicated for bedside clinical practice to support Determines risk of right ventricular heart failure in patients after left ventricular assist device (LVAD) implantation.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines. Guideline pearl: C-index: 0.70 in derivation cohort, 0.67 in validation cohort.
EUROMACS-RHF Score = (RA/PCWP >0.54 × 2) + (Hemoglobin ≤10 g/dL × 1) + (Multiple IV inotropes × 2.5) + (INTERMACS Class 1-3 × 2) + (Severe RV dysfunction × 2)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| ra_pcwp_ratio_elevated | string | Yes | Right atrial pressure to pulmonary capillary wedge pressure ratio >0.54 |
| hemoglobin_low | string | Yes | Hemoglobin ≤10 g/dL |
| multiple_inotropes | string | Yes | Multiple intravenous inotropes |
| intermacs_class_low | string | Yes | INTERMACS Class 1-3 (critical cardiogenic shock to stable but inotrope dependent) |
| severe_rv_dysfunction | string | Yes | Severe right ventricular dysfunction by echocardiogram |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–2 | Low Risk | Low risk for RHF |
| 2.5–4 | Intermediate Risk | Intermediate risk for RHF |
| 4.5–9.5 | High Risk | High risk for RHF |
Evidence-Based References (EBM)
- Soliman OII, Akin S, Muslem R, Boersma E, Manintveld OC, Krabatsch T, et al. Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: The EUROMACS (European Registry for Patients with Mechanical Circulatory Support) Right-Sided Heart Failure Risk Score. Circulation. 2018 Mar 6;137(9):891-906. doi: 10.1161/CIRCULATIONAHA.117.030543.DOI: 10.1161/CIRCULATIONAHA.117.030543
- Bellavia D, Iacovoni A, Scardulla C, Moja L, Pilato M, Kushwaha SS, et al. Prediction of right heart failure after left ventricular assist device implantation. Eur Heart J Acute Cardiovasc Care. 2017 Dec;6(8):668-676. doi: 10.1177/2048872615612455.DOI: 10.1177/2048872615612455
- Kormos RL, Cowger J, Pagani FD, Teuteberg JJ, Goldstein DJ, Jacobs JP, et al. The Society of Thoracic Surgeons Intermacs database annual report: evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant. 2019 Feb;38(2):114-126. doi: 10.1016/j.healun.2018.11.013.DOI: 10.1016/j.healun.2018.11.013